Light Sciences Oncology Finishes Enrollment in Pivotal Clinical Trial

other

▤ Summary

Light Sciences Oncology Finishes Enrollment in Pivotal Clinical Trial Xconomy Seattle — Light Sciences Oncology, a Bellevue, WA-based developer of cancer drugs, said it has completed enrollment of 200 patients with liver tumors in a clinical trial.The goal of the study is to see whether patients live longer after they get LitX.The company’s treatment is designed to use a light-emitting diode, threaded inside a tumor, to activate a drug to kill tumors within its wavelength.If the trial reaches it goal, the company plans to ask regulators in the U.S. and Europe for marketing approval in 2009.

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies